Skip to main content

EDAP TMS SA

corporate_fare Company Profile

EDAP TMS SA

FOCL·NASDAQ·Life Sciences·CIK 0001041934

FocalTherics is a medical technology company that develops, manufactures, markets, and sells non-invasive therapeutic ultrasound and energy-based medical devices. The company was founded in 1979 as a *société anonyme* (a type of public limited company) organized under French law for a duration of 60 years from its incorporation date, unless extended by shareholder approval. FocalTherics is headquartered in Vaulx-en-Velin, France, and operates in the United States, Europe, Asia, and the rest of the world. Its technologies are primarily used in urology, with a current focus on treating prostate cancer. FocalTherics is conducting clinical development activities to support potential expanded indications in urology and women's health. The company has realigned its business to focus exclusively on applications leveraging its proprietary High Intensity Focused Ultrasound (HIFU) technology, commercially driven by its flagship product, Focal One Robotic HIFU. This realignment aims to position Focal One HIFU as a differentiated platform. Focal One has achieved key regulatory milestones: On June 18, 2013, FocalTherics obtained a CE Marking for Focal One for the treatment of prostate cancer, which allowed its commercialization in the European Union and other territories requiring CE Marking. On June 7, 2018, the company received U.S. regulatory approval for Focal One.

EDAP TMS SA (NASDAQ:FOCL) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 16 items for FOCL at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-05, rated 7/10. Across its 16 most recent items scored 7 or higher, the top rating is 8/10, with 7 rated 8 or above. Recent SEC coverage for FOCL spans 10-Q, 8-K, 424B5.

Recent high-impact activity:

  • Q3 Loss Narrower Than Expected at 4 Cents, But Revenue Drops 39% and Misses
  • FocalTherics Q3 Revenue Up 26% to $9.8M; Cash Jumps to $56.3M After $42.4M Raise
  • FocalTherics Q3 Revenue Up 26% to $9.8M; 2026 Guidance Narrowed to $50-52M
  • Q3 Revenue Up 26% to $9.8M, But Guidance Range Trimmed at Top End
  • Underwriters' Full Option Exercise Lifts EDAP TMS Offering by 15%

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$70.53M
Net Income
-$29.25M
Diluted EPS
-$0.78
Op. Cash Flow
-$16.41M
Gross Profit
$30M
Operating Income
-$24.69M
Cash & Equivalents
$20.45M
Total Debt
$18.02M
Debt / Equity
0.93×
Net Margin
-41.5%
Shares Outstanding
37.48M sh
Source: 10-K · filed 2026-03-25 · accession 0001104659-26-034528

Short Interest & Short Volume

9.37 days to cover

FINRA reported short interest of 365,242 shares in FOCL as of the October 30, 2026 settlement, a 9.1% increase from the prior period — about 9.4 days to cover at its recent average daily volume. On November 19, 2026, 53.8% of FOCL volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)365,242 shares as of October 30, 2026
Change vs prior period▲ 9.1%
Days to cover9.37 at avg daily volume of 38,968
Daily short volume (FINRA facilities)53.8% of 89,606 shares on November 19, 2026
5-day average short volume39.4%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

High risk

Filing-implied dilution signals for FOCL, detected from its recent SEC filings · based on capital-structure filings through 2026-08-12.

1 recent capital raise

Offering Priced at $4.75/ADS · Significant Dilution

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with F →
$2.63 -6.74% today
52-week range · as of 2026-11-05 $1.82 – $6.4
Market cap
$133.16M
Volume
116.6K (0.6× avg)
3-mo avg 205.6K
Live data · 2026-11-20 20:40 UTC · Market open

show_chartPrice Chart

Loading chart...

feed FOCL - Latest Insights

FOCL
Nov 05, 2026, 6:50 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $3.90
Real-time Price: $2.63 info
Change: -$1.27 (-33%) info
Market Cap: $133.162M info
FOCL
Nov 05, 2026, 4:10 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $4.25
Real-time Price: $2.63 info
Change: -$1.62 (-38%) info
Market Cap: $133.162M info
FOCL
Nov 05, 2026, 4:10 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.25
Real-time Price: $2.63 info
Change: -$1.62 (-38%) info
Market Cap: $133.162M info
FOCL
Nov 05, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $4.25
Real-time Price: $2.63 info
Change: -$1.62 (-38%) info
Market Cap: $133.162M info
FOCL
Aug 19, 2026, 6:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.37
Real-time Price: $2.63 info
Change: -$1.74 (-40%) info
Market Cap: $133.162M info
FOCL
Aug 14, 2026, 4:02 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $4.76
Real-time Price: $2.63 info
Change: -$2.13 (-45%) info
Market Cap: $133.162M info
FOCL
Aug 14, 2026, 6:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.90
Real-time Price: $2.63 info
Change: -$2.27 (-46%) info
Market Cap: $133.162M info
FOCL
Aug 13, 2026, 4:02 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.59
Real-time Price: $2.63 info
Change: -$1.96 (-43%) info
Market Cap: $133.162M info
FOCL
Aug 12, 2026, 6:37 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $4.89
Real-time Price: $2.63 info
Change: -$2.26 (-46%) info
Market Cap: $133.162M info
FOCL
Aug 11, 2026, 9:10 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $5.10
Real-time Price: $2.63 info
Change: -$2.47 (-48%) info
Market Cap: $133.162M info
FOCL
Aug 11, 2026, 8:53 PM EDT
Filing Type: 424B5
Importance Score:
8
Price at Filing: $4.89
Real-time Price: $2.63 info
Change: -$2.26 (-46%) info
Market Cap: $133.162M info
FOCL
Aug 11, 2026, 5:04 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.70
Real-time Price: $2.63 info
Change: -$2.07 (-44%) info
Market Cap: $133.162M info
FOCL
Aug 11, 2026, 4:28 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $5.09
Real-time Price: $2.63 info
Change: -$2.46 (-48%) info
Market Cap: $133.162M info
FOCL
Aug 11, 2026, 4:23 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $6.01
Real-time Price: $2.63 info
Change: -$3.38 (-56%) info
Market Cap: $133.162M info
FOCL
Jun 30, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $5.15
Real-time Price: $2.63 info
Change: -$2.51 (-49%) info
Market Cap: $133.162M info
FOCL
Jun 16, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $4.75
Real-time Price: $2.63 info
Change: -$2.12 (-45%) info
Market Cap: $133.162M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets